Table 4.
Median and IQR of eGFR values and progression rate (see also Fig. 1)
| CKD-EPI | MDRD | Reference in Fig. 1 | |
|---|---|---|---|
| Median eGFR when entering in MaReA (mL/min/1.73 m2 BSA) | 12.6 (10.2; 16.0) | 14.2 (11.4; 17.9) | A |
| Annualized decrease in eGFR before entering in MaReA (mL/min/1.73 m2 BSA/year) | − 4.0 (− 7.1; − 2.2) | − 4.0 (− 7.1; − 2.2) | B |
| Median of observed eGFR at start of dialysis (mL/min/1.73 m2 BSA) | 6.7 (5.3; 8.5) | 7.7 (6.1; 9.4) | C |
| Expected lag time between entry in MaReA and start of dialysis according to extrapolation of eGFR trajectory observed before entering MaReA (months) | 17.7 (12.3; 21.9) | 19.5 (14.4; 24.3) | D |
| Annualized decrease in eGFR while in MaReA (mL/min/1.73 m2 BSA/ year) | − 2.0 (− 4.9; − 0.3) | − 2.2 (− 4.7; − 0.3) | E |
| Expected lag time from entry in MaReA to start of dialysis according to extrapolation of eGFR trajectory observed during MaReA (months) | 35.4 (24.6; 43.8) | 35.5 (26.2; 44.2) | F |
| Difference in months between real and expected start of dialysis (months) | 17.7 (1.5; 30.3) | 16.0 (1.6; 29.5) | G |